1-2 of 2
adenocarcinoma, mucinous
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax Added to Ibrutinib in High-Risk CLL Achieves a High Rate of Undetectable Minimal Residual Disease. [RTS1]

Philip A. Thompson, MBBS, Michael J Keating, MBBS, Nitin Jain, MD, Alessandra Ferrajoli, MD, Tapan M. Kadia, MD, Prithviraj Bose, MD, William G. Wierda, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 358.
https://doi.org/10.1182/blood-2019-129230
Published: 2019
Journal Articles

Microparticle-Associated Tissue Factor Activity: A Link between Cancer and Thrombosis?.

Margot E.T. Tesselaar, MD, Fred P.H.T.M. Romijn, Irma K. van der Linden, Frans Prins, Rogier M. Bertina, PhD, Susanne Osanto, PhD
Journal: Blood
Blood (2005) 106 (11): 260.
https://doi.org/10.1182/blood.V106.11.260.260
Published: 2005